Literature DB >> 142067

The relation between B-cell stimulation and delayed hypersensitivity. The effect of cyclophosphamide pretreatment on antibody production.

B Noble, D Parker, R J Scheper, J L Turk.   

Abstract

Cyclophosphamide (CY), which can enhance some forms of delayed-type hypersensitivity if given 3 days before immunization, is also a potent suppressor of most antibody mediated 4-h skin reactions to protein antigens. However many haemagglutinating antibodies, which are present in serum at the time of skin testing, are not similarly suppressed. Antibody titres in some sera recovered from CY-pretreated guinea-pigs differ little from titres in control sera. This resistance to CY suggests that long-lived precursors characterize the B-cell lines that produce many haemagglutinating antibodies, whereas the CY-sensitive precursors of skin reactive antibodies, which mediate Arthus-type reactions, are probably rapidly dividing, short-lived cells. Furthermore, the novel appearance of BGG antibodies in sera from CY-pretreated animals immunized with DNP50-BGG indicates that haemagglutinating antibody responses to some antigens are regulated by CY-sensitive mechanisms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142067      PMCID: PMC1445440     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  PREPARATION OF PURIFIED ANTI-2,4-DINITROPHENYL ANTIBODIES.

Authors:  H N EISEN
Journal:  Methods Med Res       Date:  1964

2.  IMMUNOLOGIC UNRESPONSIVENESS IN THE ADULT GUINEA PIG. I. SUPPRESSION OF DELAYED HYPERSENSITIVITY AND ANTIBODY FORMATION TO PROTEIN ANTIGENS.

Authors:  H F DVORAK; J B BILLOTE; J S MCCARTHY; M H FLAX
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  B-cell suppression of delayed hypersensitivity reactions.

Authors:  S I Katz; D Parker; J L Turk
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

4.  A buffered chromic chloride method of attaching antigens to red cells: use in haemagglutination.

Authors:  R N Poston
Journal:  J Immunol Methods       Date:  1974-05       Impact factor: 2.303

5.  Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity.

Authors:  L Polak; J L Turk
Journal:  Nature       Date:  1974-06-14       Impact factor: 49.962

6.  The relation of immune depression and B-cell stimulation during the development of delayed hypersensitivity to soluble antigens.

Authors:  R J Scheper; D Parker; B Noble; J L Turk
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

7.  The influence of cyclophosphamide on antibody formation in the mouse.

Authors:  J M Willers; E Sluis
Journal:  Ann Immunol (Paris)       Date:  1975-04

Review 8.  Control mechanisms in delayed-type hypersensitivity.

Authors:  J L Turk; L Polak; D Parker
Journal:  Br Med Bull       Date:  1976-05       Impact factor: 4.291

9.  Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity.

Authors:  J L Turk; D Parker
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

10.  Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.

Authors:  P H Lagrange; G B Mackaness; T E Miller
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  8 in total

1.  The effect of cyclophosphamide pretreatment on B-cell stimulation: dissociation of action on homocytotropic antibody and other B-cell functions.

Authors:  D Parker; J L Turk
Journal:  Immunology       Date:  1978-01       Impact factor: 7.397

2.  The influence of cyclophosphamide and 6-mercaptopurine on the IgG1 and IgG2 immune response in guinea-pigs.

Authors:  K Drössler; F Klima; H Ambrosius
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

3.  The regulation of T cell responses by spontaneously active suppressor cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

4.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

5.  Contact sensitivity and the DNA response in mice to high and low doses of oxazolone: low dose unresponsiveness following painting and feeding and its prevention by pretreatment with cyclophosphamide.

Authors:  G L Asherson; M A Perera; W R Thomas
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

6.  Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization.

Authors:  J Cottney; J Bruin; A J Lewis
Journal:  Agents Actions       Date:  1980-09

7.  Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.

Authors:  H C Stevenson; A S Fauci
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

8.  Effects of pulse cyclophosphamide on NZB/W disease.

Authors:  D Chia; L Levy; E V Barnett; W H Carnes
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.